JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway
Yaru Lu, Qian Ma, Lu Yu, Huan Huang, Xiaoxi Liu, Pei Chen, Hao Ran, Weibin Liu, Weibin Liu
Topics & Concepts
Myasthenia gravisProtein kinase BPI3K/AKT/mTOR pathwayProinflammatory cytokineSignal transductionSTAT3Cancer researchPharmacologyImmunologyChemistryBiologyCell biologyInflammationMyasthenia Gravis and ThymomaAdrenal Hormones and DisordersPsoriasis: Treatment and Pathogenesis